BB Biotech Confirms Profit and Lowers Dividend
The investment company BB Biotech, which specializes in the pharmaceutical sector, has confirmed its preliminary figures for the 2024 financial year. Looking ahead, increased activity is expected. However, there is uncertainty regarding regulatory conditions in the United States.